<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35946434</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1754-8411</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Disease models &amp; mechanisms</Title><ISOAbbreviation>Dis Model Mech</ISOAbbreviation></Journal><ArticleTitle>Transcriptional targets of amyotrophic lateral sclerosis/frontotemporal dementia protein TDP-43 - meta-analysis and interactive graphical database.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">dmm049418</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1242/dmm.049418</ELocationID><Abstract><AbstractText>TDP-43 proteinopathy is the major pathology in amyotrophic lateral sclerosis (ALS) and tau-negative frontotemporal dementia (FTD). Mounting evidence implicates loss of normal TDP-43 RNA-processing function as a key pathomechanism. However, the RNA targets of TDP-43 differ by report, and have never been formally collated or compared between models and disease, hampering understanding of TDP-43 function. Here, we conducted re-analysis and meta-analysis of publicly available RNA-sequencing datasets from six TDP-43-knockdown models, and TDP-43-immunonegative neuronal nuclei from ALS/FTD brain, to identify differentially expressed genes (DEGs) and differential exon usage (DEU) events. There was little overlap in DEGs between knockdown models, but PFKP, STMN2, CFP, KIAA1324 and TRHDE were common targets and were also differentially expressed in TDP-43-immunonegative neurons. DEG enrichment analysis revealed diverse biological pathways including immune and synaptic functions. Common DEU events in human datasets included well-known targets POLDIP3 and STMN2, and novel targets EXD3, MMAB, DLG5 and GOSR2. Our interactive database (https://www.scotterlab.auckland.ac.nz/research-themes/tdp43-lof-db/) allows further exploration of TDP-43 DEG and DEU targets. Together, these data identify TDP-43 targets that can be exploited therapeutically or used to validate loss-of-function processes. This article has an associated First Person interview with the first author of the paper.</AbstractText><CopyrightInformation>&#xa9; 2022. Published by The Company of Biologists Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Maize C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>School of Biological Sciences and Centre for Brain Research, University of Auckland, 3A Symonds Street, Auckland 1010, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scotter</LastName><ForeName>Emma L</ForeName><Initials>EL</Initials><Identifier Source="ORCID">0000-0003-4064-3599</Identifier><AffiliationInfo><Affiliation>School of Biological Sciences and Centre for Brain Research, University of Auckland, 3A Symonds Street, Auckland 1010, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Dis Model Mech</MedlineTA><NlmUniqueID>101483332</NlmUniqueID><ISSNLinking>1754-8403</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Differentially expressed genes</Keyword><Keyword MajorTopicYN="N">Exon usage</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Loss of function</Keyword><Keyword MajorTopicYN="N">RNA-seq</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword></KeywordList><CoiStatement>Competing interests The authors declare no competing or financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>10</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35946434</ArticleId><ArticleId IdType="pmc">PMC9509890</ArticleId><ArticleId IdType="doi">10.1242/dmm.049418</ArticleId><ArticleId IdType="pii">276263</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Amador-Ortiz, C., Lin, W.-L., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff-Radford, N. R., Hutton, M. L. and Dickson, D. W. (2007). TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann. Neurol. 61, 435-445. 10.1002/ana.21154</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21154</ArticleId><ArticleId IdType="pmc">PMC2677204</ArticleId><ArticleId IdType="pubmed">17469117</ArticleId></ArticleIdList></Reference><Reference><Citation>Amlie-Wolf, A., Ryvkin, P., Tong, R., Dragomir, I., Suh, E. R., Xu, Y., Van Deerlin, V. M., Gregory, B. D., Kwong, L. K., Trojanowski, J. Q.et al. (2015). Transcriptomic changes due to cytoplasmic TDP-43 expression reveal dysregulation of histone transcripts and nuclear chromatin. PLoS ONE 10, e0141836. 10.1371/journal.pone.0141836</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0141836</ArticleId><ArticleId IdType="pmc">PMC4624943</ArticleId><ArticleId IdType="pubmed">26510133</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders, S., Reyes, A. and Huber, W. (2012). Detecting differential usage of exons from RNA-seq data. Genome Res. 22, 2008-2017. 10.1101/gr.133744.111</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.133744.111</ArticleId><ArticleId IdType="pmc">PMC3460195</ArticleId><ArticleId IdType="pubmed">22722343</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansarullah, W., Jain, C., Far, F. F., Homberg, S., Wissmiller, K., Von Hahn, F. G., Raducanu, A., Schirge, S., Sterr, M., Bilekova, S.et al. (2021). Inceptor counteracts insulin signalling in beta-cells to control glycaemia. Nature 590, 326-331. 10.1038/s41586-021-03225-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03225-8</ArticleId><ArticleId IdType="pubmed">33505018</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y.et al. (2006). TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602-611. 10.1016/j.bbrc.2006.10.093</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai, T., Mackenzie, I. R. A., Hasegawa, M., Nonoka, T., Niizato, K., Tsuchiya, K., Iritani, S., Onaya, M. and Akiyama, H. (2009). Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol. 117, 125-136. 10.1007/s00401-008-0480-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0480-1</ArticleId><ArticleId IdType="pubmed">19139911</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnone, J. T., Robbins-Pianka, A., Arace, J. R., Kass-Gergi, S. and Mcalear, M. A. (2012). The adjacent positioning of co-regulated gene pairs is widely conserved across eukaryotes. BMC Genomics 13, 546. 10.1186/1471-2164-13-546</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-13-546</ArticleId><ArticleId IdType="pmc">PMC3500266</ArticleId><ArticleId IdType="pubmed">23051624</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi, G., Rezaei Varmaziar, F., Karimi, M., Rajabinejad, M., Ranjbar, S., Gorgin Karaji, A., Salari, F., Afshar Hezarkhani, L. and Rezaiemanesh, A. (2021). Determination of the transcriptional level of long non-coding RNA NEAT-1, downstream target microRNAs, and genes targeted by microRNAs in diabetic neuropathy patients. Immunol. Lett. 232, 20-26. 10.1016/j.imlet.2021.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2021.01.007</ArticleId><ArticleId IdType="pubmed">33508370</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala, Y. M., De Conti, L., Avenda&#xf1;o-V&#xe1;zquez, S. E., Dhir, A., Romano, M., D'Ambrogio, A., Tollervey, J., Ule, J., Baralle, M., Buratti, E.et al. (2011). TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 30, 277-288. 10.1038/emboj.2010.310</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.310</ArticleId><ArticleId IdType="pmc">PMC3025456</ArticleId><ArticleId IdType="pubmed">21131904</ArticleId></ArticleIdList></Reference><Reference><Citation>Bas, E., Goncalves, S., Adams, M., Dinh, C. T., Bas, J. M. and Van De Water, T. R. (2015). Spiral ganglion cells and macrophages initiate neuro-inflammation and scarring following cochlear implantation. Front. Cell Neurosci. 9, 303. 10.3389/fncel.2015.00303</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00303</ArticleId><ArticleId IdType="pmc">PMC4532929</ArticleId><ArticleId IdType="pubmed">26321909</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker, L. A., Huang, B., Bieri, G., Ma, R., Knowles, D. A., Jafar-Nejad, P., Messing, J., Kim, H. J., Soriano, A., Auburger, G.et al. (2017). Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature 544, 367-371. 10.1038/nature22038</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22038</ArticleId><ArticleId IdType="pmc">PMC5642042</ArticleId><ArticleId IdType="pubmed">28405022</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkovits, B. D. and Mayr, C. (2015). Alternative 3&#x2032; UTRs act as scaffolds to regulate membrane protein localization. Nature 522, 363-367. 10.1038/nature14321</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14321</ArticleId><ArticleId IdType="pmc">PMC4697748</ArticleId><ArticleId IdType="pubmed">25896326</ArticleId></ArticleIdList></Reference><Reference><Citation>Birsa, N., Bentham, M. P. and Fratta, P. (eds). (2020). Cytoplasmic functions of TDP-43 and FUS and their role in ALS. Semin. Cell Dev. Biol. 99, 193-201. 10.1016/j.semcdb.2019.05.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.05.023</ArticleId><ArticleId IdType="pubmed">31132467</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolger, A. M., Lohse, M. and Usadel, B. (2014). Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114-2120. 10.1093/bioinformatics/btu170</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu170</ArticleId><ArticleId IdType="pmc">PMC4103590</ArticleId><ArticleId IdType="pubmed">24695404</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden, H. A. and Dormann, D. (2016). Altered mRNP granule dynamics in FTLD pathogenesis. J. Neurochem. 138 Suppl. 1, 112-133. 10.1111/jnc.13601</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13601</ArticleId><ArticleId IdType="pubmed">26938019</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak, H. and Del Tredici, K. (2018). Anterior cingulate cortex TDP-43 pathology in sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 77, 74-83. 10.1093/jnen/nlx104</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlx104</ArticleId><ArticleId IdType="pubmed">29186496</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak, H., Ludolph, A. C., Neumann, M., Ravits, J. and Del Tredici, K. (2017). Pathological TDP-43 changes in Betz cells differ from those in bulbar and spinal &#x3b1;-motoneurons in sporadic amyotrophic lateral sclerosis. Acta Neuropathol. 133, 79-90. 10.1007/s00401-016-1633-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1633-2</ArticleId><ArticleId IdType="pmc">PMC5209403</ArticleId><ArticleId IdType="pubmed">27757524</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider, J., Del Tredici, K., Toledo, J. B., Robinson, J. L., Irwin, D. J., Grossman, M., Suh, E. R., Van Deerlin, V. M., Wood, E. M., Baek, Y.et al. (2013). Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 74, 20-38. 10.1002/ana.23937</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider, J., Arai, K., Del Tredici, K., Toledo, J. B., Robinson, J. L., Lee, E. B., Kuwabara, S., Shibuya, K., Irwin, D. J., Fang, L.et al. (2014). TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol. 128, 423-437. 10.1007/s00401-014-1299-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1299-6</ArticleId><ArticleId IdType="pmc">PMC4384652</ArticleId><ArticleId IdType="pubmed">24916269</ArticleId></ArticleIdList></Reference><Reference><Citation>Broeck, L. V., Callaerts, P. and Dermaut, B. (2014). TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis? Trends Mol. Med. 20, 66-71. 10.1016/j.molmed.2013.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2013.11.003</ArticleId><ArticleId IdType="pubmed">24355761</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti, E. and Baralle, F. E. (2008). Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front. Biosci. 13, 867-878. 10.2741/2727</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/2727</ArticleId><ArticleId IdType="pubmed">17981595</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti, E. and Baralle, F. E. (2010). The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol. 7, 420-429. 10.4161/rna.7.4.12205</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rna.7.4.12205</ArticleId><ArticleId IdType="pubmed">20639693</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti, E., Dork, T., Zuccato, E., Pagani, F., Romano, M. and Baralle, F. E. (2001). Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J. 20, 1774-1784. 10.1093/emboj/20.7.1774</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/20.7.1774</ArticleId><ArticleId IdType="pmc">PMC145463</ArticleId><ArticleId IdType="pubmed">11285240</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti, E., Brindisi, A., Pagani, F. and Baralle, F. E. (2004). Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance. Am. J. Hum. Genet. 74, 1322-1325. 10.1086/420978</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/420978</ArticleId><ArticleId IdType="pmc">PMC1182100</ArticleId><ArticleId IdType="pubmed">15195661</ArticleId></ArticleIdList></Reference><Reference><Citation>Butzkueven, H., Kappos, L., Pellegrini, F., Trojano, M., Wiendl, H., Patel, R. N., Zhang, A., Hotermans, C. and Belachew, S. (2014). Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results. J. Neurol. Neurosurg. Psychiatry 85, 1190-1197. 10.1136/jnnp-2013-306936</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-306936</ArticleId><ArticleId IdType="pmc">PMC4215289</ArticleId><ArticleId IdType="pubmed">24532785</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, H.-J., Topp, S. D., Hui, H. S., Zacco, E., Katarya, M., Mcloughlin, C., King, A., Smith, B. N., Troakes, C., Pastore, A.et al. (2019). RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy. Brain 142, 3753-3770. 10.1093/brain/awz313</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz313</ArticleId><ArticleId IdType="pmc">PMC6885686</ArticleId><ArticleId IdType="pubmed">31605140</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita, C., Onesto, E., Buratti, E., De La Grange, P., Gumina, V., Baralle, F. E., Silani, V. and Ratti, A. (2015). From transcriptomic to protein level changes in TDP-43 and FUS loss-of-function cell models. Biochim. Biophys. Acta 1849, 1398-1410. 10.1016/j.bbagrm.2015.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagrm.2015.10.015</ArticleId><ArticleId IdType="pubmed">26514432</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne, A. N., Baskerville, V., Zaepfel, B. L., Dickson, D. W., Rigo, F., Bennett, F., Lusk, C. P. and Rothstein, J. D. (2021). Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS. Sci. Transl. Med. 13, eabe1923. 10.1126/scitranslmed.abe1923</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abe1923</ArticleId><ArticleId IdType="pmc">PMC9022198</ArticleId><ArticleId IdType="pubmed">34321318</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham, F., Allen, J. E., Allen, J., Alvarez-Jarreta, J., Amode, M. R., Armean, I. M., Austine-Orimoloye, O., Azov, A. G., Barnes, I., Bennett, R.et al. (2022). Ensembl 2022. Nucleic Acids Res. 50, D988-DD95. 10.1093/nar/gkab1049</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab1049</ArticleId><ArticleId IdType="pmc">PMC8728283</ArticleId><ArticleId IdType="pubmed">34791404</ArticleId></ArticleIdList></Reference><Reference><Citation>De Conti, L., Akinyi, M. V., Mendoza-Maldonado, R., Romano, M., Baralle, M. and Buratti, E. (2015). TDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways. Nucleic Acids Res. 43, 8990-9005. 10.1093/nar/gkv814</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv814</ArticleId><ArticleId IdType="pmc">PMC4605304</ArticleId><ArticleId IdType="pubmed">26261209</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng, L., Feng, J. and Broaddus, R. R. (2010). The novel estrogen-induced gene EIG121 regulates autophagy and promotes cell survival under stress. Cell Death Dis. 1, e32. 10.1038/cddis.2010.9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2010.9</ArticleId><ArticleId IdType="pmc">PMC2976047</ArticleId><ArticleId IdType="pubmed">21072319</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewan, R., Chia, R., Ding, J., Hickman, R. A., Stein, T. D., Abramzon, Y., Ahmed, S., Sabir, M. S., Portley, M. K., Tucci, A.et al. (2021). Pathogenic Huntingtin repeat expansions in patients with frontotemporal dementia and amyotrophic lateral sclerosis. Neuron 109, 448-60.e4. 10.1016/j.neuron.2020.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.11.005</ArticleId><ArticleId IdType="pmc">PMC7864894</ArticleId><ArticleId IdType="pubmed">33242422</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhir, A. and Buratti, E. (2010). Alternative splicing: role of pseudoexons in human disease and potential therapeutic strategies. FEBS J. 277, 841-855. 10.1111/j.1742-4658.2009.07520.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2009.07520.x</ArticleId><ArticleId IdType="pubmed">20082636</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson, C. M., Wai, T., Leclerc, D., Kadir, H., Narang, M. and Lerner-Ellis, J. P. (2002). Identification of the gene responsible for the cblB complementation group of vitamin B12-dependent methylmalonic aciduria. Hum. Mol. Genet. 11, 3361-3369. 10.1093/hmg/11.26.3361</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/11.26.3361</ArticleId><ArticleId IdType="pubmed">12471062</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden, A. C., Kim, H.-J., Hart, M. P., Chen-Plotkin, A. S., Johnson, B. S., Fang, X., Armakola, M., Geser, F., Greene, R., Lu, M. M.et al. (2010). Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466, 1069-1075. 10.1038/nature09320</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini, C., Bassell, G. J. and Rossoll, W. (2012). The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth. Hum. Mol. Genet. 21, 3703-3718. 10.1093/hmg/dds205</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds205</ArticleId><ArticleId IdType="pmc">PMC3406762</ArticleId><ArticleId IdType="pubmed">22641816</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes, N., Eshleman, N. and Buchan, J. R. (2018). Stress granules and ALS: a case of causation or correlation? Adv. Neurobiol. 20, 173-212. 10.1007/978-3-319-89689-2_7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-89689-2_7</ArticleId><ArticleId IdType="pubmed">29916020</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiesel, F. C., Weber, S. S., Supper, J., Zell, A. and Kahle, P. J. (2012). TDP-43 regulates global translational yield by splicing of exon junction complex component SKAR. Nucleic Acids Res. 40, 2668-2682. 10.1093/nar/gkr1082</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr1082</ArticleId><ArticleId IdType="pmc">PMC3315294</ArticleId><ArticleId IdType="pubmed">22121224</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudet, P., Livstone, M. S., Lewis, S. E. and Thomas, P. D. (2011). Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Brief. Bioinform. 12, 449-462. 10.1093/bib/bbr042</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbr042</ArticleId><ArticleId IdType="pmc">PMC3178059</ArticleId><ArticleId IdType="pubmed">21873635</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu, G. J., Lund, H., Wu, D., Blokzijl, A., Classon, C., Von Euler, G., Landegren, U., Sunnemark, D. and Kamali-Moghaddam, M. (2013). Role of individual MARK isoforms in phosphorylation of tau at Ser(2)(6)(2) in Alzheimer's disease. Neuromolecular Med. 15, 458-469. 10.1007/s12017-013-8232-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-013-8232-3</ArticleId><ArticleId IdType="pubmed">23666762</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashi, S., Iseki, E., Yamamoto, R., Minegishi, M., Hino, H., Fujisawa, K., Togo, T., Katsuse, O., Uchikado, H., Furukawa, Y.et al. (2007). Concurrence of TDP-43, tau and &#x3b1;-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res. 1184, 284-294. 10.1016/j.brainres.2007.09.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2007.09.048</ArticleId><ArticleId IdType="pubmed">17963732</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey, J., Emmett, W., Fratta, P., Isaacs, A. M. and Plagnol, V. (2017). Quantitative analysis of cryptic splicing associated with TDP-43 depletion. BMC Med Genomics 10, 38. 10.1186/s12920-017-0274-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-017-0274-1</ArticleId><ArticleId IdType="pmc">PMC5446763</ArticleId><ArticleId IdType="pubmed">28549443</ArticleId></ArticleIdList></Reference><Reference><Citation>James, B. D., Wilson, R. S., Boyle, P. A., Trojanowski, J. Q., Bennett, D. A. and Schneider, J. A. (2016). TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia. Brain 139, 2983-2993. 10.1093/brain/aww224</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww224</ArticleId><ArticleId IdType="pmc">PMC5091047</ArticleId><ArticleId IdType="pubmed">27694152</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong, Y. H., Ling, J. P., Lin, S. Z., Donde, A. N., Braunstein, K. E., Majounie, E., Traynor, B. J., LaClair, K. D., Lloyd, T. E. and Wong, P. C.et al. (2017). Tdp-43 cryptic exons are highly variable between cell types. Mol. Neurodegener. 12, 1-9. 10.1186/s13024-016-0144-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0144-x</ArticleId><ArticleId IdType="pmc">PMC5289002</ArticleId><ArticleId IdType="pubmed">28153034</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, B. S., Mccaffery, J. M., Lindquist, S. and Gitler, A. D. (2008). A yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA 105, 6439-6444. 10.1073/pnas.0802082105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0802082105</ArticleId><ArticleId IdType="pmc">PMC2359814</ArticleId><ArticleId IdType="pubmed">18434538</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, J. O., Pioro, E. P., Boehringer, A., Chia, R., Feit, H., Renton, A. E., Pliner, H. A., Abramzon, Y., Marangi, G., Winborn, B. J.et al. (2014). Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci. 17, 664-666. 10.1038/nn.3688</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3688</ArticleId><ArticleId IdType="pmc">PMC4000579</ArticleId><ArticleId IdType="pubmed">24686783</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly, J. A., Boyle, N. T., Cole, N., Slator, G. R., Colivicchi, M. A., Stefanini, C., Gobbo, O. L., Scalabrino, G. A., Ryan, S. M., Elamin, M.et al. (2015). First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models. Neuropharmacology 89, 193-203. 10.1016/j.neuropharm.2014.09.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2014.09.024</ArticleId><ArticleId IdType="pubmed">25281210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidmose, R. T., Laursen, N. S., Dob&#xf3;, J., Kjaer, T. R., Sirotkina, S., Yatime, L., Sottrup-Jensen, L., Thiel, S., G&#xe1;l, P. and Andersen, G. R. (2012). Structural basis for activation of the complement system by component C4 cleavage. Proc. Natl. Acad. Sci. USA 109, 15425-15430. 10.1073/pnas.1208031109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1208031109</ArticleId><ArticleId IdType="pmc">PMC3458355</ArticleId><ArticleId IdType="pubmed">22949645</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, H. J., Kim, N. C., Wang, Y.-D., Scarborough, E. A., Moore, J., Diaz, Z., Maclea, K. S., Freibaum, B., Li, S., Molliex, A.et al. (2013). Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495, 467-473. 10.1038/nature11922</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim, J. R., Williams, L. A., Limone, F., Guerra San Juan, I., Davis-Dusenbery, B. N., Mordes, D. A., Burberry, A., Steinbaugh, M. J., Gamage, K. K., Kirchner, R.et al. (2019). ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 22, 167-179. 10.1038/s41593-018-0300-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0300-4</ArticleId><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Larocca, T. J., Mariani, A., Watkins, L. R. and Link, C. D. (2019). TDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes. Neurobiol. Dis. 132, 104514. 10.1016/j.nbd.2019.104514</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104514</ArticleId><ArticleId IdType="pmc">PMC6834892</ArticleId><ArticleId IdType="pubmed">31229690</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y., Ray, P., Rao, E. J., Shi, C., Guo, W., Chen, X., Woodruff, E. A., Fushimi, K. and Wu, J. Y. (2010). A Drosophila model for TDP-43 proteinopathy. Proc. Natl. Acad. Sci. USA 107, 3169-3174. 10.1073/pnas.0913602107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0913602107</ArticleId><ArticleId IdType="pmc">PMC2840283</ArticleId><ArticleId IdType="pubmed">20133767</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, X., Cooper, N. G. F., O'toole, T. E. and Rouchka, E. C. (2020). Choice of library size normalization and statistical methods for differential gene expression analysis in balanced two-group comparisons for RNA-seq studies. BMC Genomics 21, 75. 10.1186/s12864-020-6502-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-020-6502-7</ArticleId><ArticleId IdType="pmc">PMC6986029</ArticleId><ArticleId IdType="pubmed">31992223</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling, S.-C., Albuquerque, C. P., Han, J. S., Lagier-Tourenne, C., Tokunaga, S., Zhou, H. and Cleveland, D. W. (2010). ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc. Natl. Acad. Sci. USA 107, 13318-13323. 10.1073/pnas.1008227107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1008227107</ArticleId><ArticleId IdType="pmc">PMC2922163</ArticleId><ArticleId IdType="pubmed">20624952</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling, S.-C., Polymenidou, M. and Cleveland, D. W. (2013). Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79, 416-438. 10.1016/j.neuron.2013.07.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling, J. P., Pletnikova, O., Troncoso, J. C. and Wong, P. C. (2015). TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science 349, 650-655. 10.1126/science.aab0983</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aab0983</ArticleId><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y.-C., Chiang, P.-M. and Tsai, K.-J. (2013). Disease animal models of TDP-43 proteinopathy and their pre-clinical applications. Int. J. Mol. Sci. 14, 20079-20111. 10.3390/ijms141020079</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms141020079</ArticleId><ArticleId IdType="pmc">PMC3821604</ArticleId><ArticleId IdType="pubmed">24113586</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, E. Y., Russ, J., Cali, C. P., Phan, J. M., Amlie-Wolf, A. and Lee, E. B. (2019). Loss of nuclear TDP-43 is associated with decondensation of LINE retrotransposons. Cell Rep. 27, 1409-21.e6. 10.1016/j.celrep.2019.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.04.003</ArticleId><ArticleId IdType="pmc">PMC6508629</ArticleId><ArticleId IdType="pubmed">31042469</ArticleId></ArticleIdList></Reference><Reference><Citation>Lockhart, P. J., Hulihan, M., Lincoln, S., Hussey, J., Skipper, L., Bisceglio, G., Wilkes, K. and Farrer, M. J. (2004). Identification of the human ubiquitin specific protease 31 (USP31) gene: structure, sequence and expression analysis. DNA Seq. 15, 9-14. 10.1080/10855660310001638197</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10855660310001638197</ArticleId><ArticleId IdType="pubmed">15354349</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeffen, J. L. C. M., Triepels, R. H., Van Den Heuvel, L. P., Schuelke, M., Buskens, C. A. F., Smeets, R. J. P., Trijbels, J. M. F. and Smeitink, J. A. M. (1998). cDNA of eight nuclear encoded subunits of NADH:ubiquinone oxidoreductase: human complex I cDNA characterization completed. Biochem. Biophys. Res. Commun. 253, 415-422. 10.1006/bbrc.1998.9786</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1998.9786</ArticleId><ArticleId IdType="pubmed">9878551</ArticleId></ArticleIdList></Reference><Reference><Citation>Love, M. I., Huber, W. and Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. 10.1186/s13059-014-0550-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe, S. L., Peter, F., Subramaniam, V. N., Wong, S. H. and Hong, W. (1997). A SNARE involved in protein transport through the Golgi apparatus. Nature 389, 881-884. 10.1038/39923</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/39923</ArticleId><ArticleId IdType="pubmed">9349823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma, X. M., Yoon, S.-O., Richardson, C. J., J&#xfc;lich, K. and Blenis, J. (2008). SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs. Cell 133, 303-313. 10.1016/j.cell.2008.02.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.02.031</ArticleId><ArticleId IdType="pubmed">18423201</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald, P. M. and Struhl, G. (1988). cis-acting sequences responsible for anterior localization of bicoid mRNA in Drosophila embryos. Nature 336, 595-598. 10.1038/336595a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/336595a0</ArticleId><ArticleId IdType="pubmed">3143913</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie, I. R. A., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., Cairns, N. J., Kwong, L. K., Forman, M. S., Ravits, J., Stewart, H.et al. (2007). Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 61, 427-434. 10.1002/ana.21147</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21147</ArticleId><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie, I. R., Arzberger, T., Kremmer, E., Troost, D., Lorenzl, S., Mori, K., Weng, S.-M., Haass, C., Kretzschmar, H. A., Edbauer, D.et al. (2013). Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol. 126, 859-879. 10.1007/s00401-013-1181-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1181-y</ArticleId><ArticleId IdType="pubmed">24096617</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo, E., Lorenzini, I., Barrameda, D., O'Conner, A. G., Barrows, J. M., Starr, A., Kovalik, T., Rabichow, B. E., Lehmkuhl, E. M., Shreiner, D. D.et al. (2019). Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. eLife 8, e45114. 10.7554/eLife.45114</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.45114</ArticleId><ArticleId IdType="pmc">PMC6557627</ArticleId><ArticleId IdType="pubmed">31180318</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayr, C. (2017). Regulation by 3&#x2032;-untranslated regions. Annu. Rev. Genet. 51, 171-194. 10.1146/annurev-genet-120116-024704</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genet-120116-024704</ArticleId><ArticleId IdType="pubmed">28853924</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcaleese, K. E., Walker, L., Erskine, D., Thomas, A. J., Mckeith, I. G. and Attems, J. J. B. (2017). TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing. Brain Pathol. 27, 472-479. 10.1111/bpa.12424</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12424</ArticleId><ArticleId IdType="pmc">PMC8029292</ArticleId><ArticleId IdType="pubmed">27495267</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijlink, F., Curran, T., Miller, A. D. and Verma, I. M. (1985). Removal of a 67-base-pair sequence in the noncoding region of protooncogene fos converts it to a transforming gene. Proc. Natl. Acad. Sci. USA 82, 4987-4991. 10.1073/pnas.82.15.4987</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.82.15.4987</ArticleId><ArticleId IdType="pmc">PMC390483</ArticleId><ArticleId IdType="pubmed">2991903</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed, Z., L&#xf3;pez-Erauskin, J., Baughn, M. W., Zhang, O., Drenner, K., Sun, Y., Freyermuth, F., McMahon, M. A., Beccari, M. S., Artates, J. W.et al. (2019). Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 22, 180-190. 10.1038/s41593-018-0293-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0293-z</ArticleId><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihevc, S. P., Baralle, M., Buratti, E. and Rogelj, B. (2016). TDP-43 aggregation mirrors TDP-43 knockdown, affecting the expression levels of a common set of proteins. Sci. Rep. 6, 33996. 10.1038/srep33996</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep33996</ArticleId><ArticleId IdType="pmc">PMC5036055</ArticleId><ArticleId IdType="pubmed">27665936</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, G. M. and Madras, B. K. (2002). Polymorphisms in the 3&#x2032;-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol. Psychiatry 7, 44-55. 10.1038/sj.mp.4000921</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.mp.4000921</ArticleId><ArticleId IdType="pubmed">11803445</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra, J., Guerrero, E. N., Hegde, P. M., Liachko, N. F., Wang, H., Vasquez, V., Gao, J., Pandey, A., Taylor, J. P., Kraemer, B. C.et al. (2019). Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proc. Natl. Acad. Sci. USA 116, 4696-4705. 10.1073/pnas.1818415116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1818415116</ArticleId><ArticleId IdType="pmc">PMC6410842</ArticleId><ArticleId IdType="pubmed">30770445</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex, A., Temirov, J., Lee, J., Coughlin, M., Kanagaraj, A. P., Kim, H. J., Mittag, T. and Taylor, J. P. (2015). Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell 163, 123-133. 10.1016/j.cell.2015.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch, C., Rosenbohm, A., Sperfeld, A.-D., Uttner, I., Reske, S., Krause, B. J., Sedlmeier, R., Meyer, T., Hanemann, C. O., Stumm, G.et al. (2005). Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann. Neurol. 58, 777-780. 10.1002/ana.20631</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20631</ArticleId><ArticleId IdType="pubmed">16240349</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutihac, R., Alegre-Abarrategui, J., Gordon, D., Farrimond, L., Yamasaki-Mann, M., Talbot, K. and Wade-Martins, R. (2015). TARDBP pathogenic mutations increase cytoplasmic translocation of TDP-43 and cause reduction of endoplasmic reticulum Ca(2)(+) signaling in motor neurons. Neurobiol. Dis. 75, 64-77. 10.1016/j.nbd.2014.12.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.12.010</ArticleId><ArticleId IdType="pubmed">25526708</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakashima-Yasuda, H., Uryu, K., Robinson, J., Xie, S. X., Hurtig, H., Duda, J. E., Arnold, S. E., Siderowf, A., Grossman, M., Leverenz, J. B.et al. (2007). Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 114, 221-229. 10.1007/s00401-007-0261-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0261-2</ArticleId><ArticleId IdType="pubmed">17653732</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M.et al. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133. 10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Novick, D., Kim, S.-H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A. and Rubinstein, M. (1999). Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10, 127-136. 10.1016/S1074-7613(00)80013-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(00)80013-8</ArticleId><ArticleId IdType="pubmed">10023777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou, S. H., Wu, F., Harrich, D., Garc&#xed;a-Mart&#xed;nez, L. F. and Gaynor, R. B. (1995). Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 69, 3584-3596. 10.1128/jvi.69.6.3584-3596.1995</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.69.6.3584-3596.1995</ArticleId><ArticleId IdType="pmc">PMC189073</ArticleId><ArticleId IdType="pubmed">7745706</ArticleId></ArticleIdList></Reference><Reference><Citation>Park, Y.-Y., Kim, S.-B., Han, H. D., Sohn, B. H., Kim, J. H., Liang, J., Lu, Y., Rodriguez-Aguayo, C., Lopez-Berestein, G., Mills, G. B.et al. (2013). Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520. J. Hepatol. 58, 182-191. 10.1002/hep.26310</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.26310</ArticleId><ArticleId IdType="pmc">PMC3923572</ArticleId><ArticleId IdType="pubmed">23389994</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen, D. V., Roumenina, L., Jensen, R. K., Gadeberg, T. A. F., Marinozzi, C., Picard, C., Rybkine, T., Thiel, S., S&#xf8;rensen, U. B. S., Stover, C.et al. (2017). Functional and structural insight into properdin control of complement alternative pathway amplification. EMBO J. 36, 1084-1099. 10.15252/embj.201696173</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201696173</ArticleId><ArticleId IdType="pmc">PMC5391138</ArticleId><ArticleId IdType="pubmed">28264884</ArticleId></ArticleIdList></Reference><Reference><Citation>Pertea, M., Kim, D., Pertea, G. M., Leek, J. T. and Salzberg, S. L. (2016). Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nat. Protoc. 11, 1650-1667. 10.1038/nprot.2016.095</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2016.095</ArticleId><ArticleId IdType="pmc">PMC5032908</ArticleId><ArticleId IdType="pubmed">27560171</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinarbasi, E. S., Ca&#x11f;atay, T., Fung, H. Y. J., Li, Y. C., Chook, Y. M. and Thomas, P. J. (2018). Active nuclear import and passive nuclear export are the primary determinants of TDP-43 localization. Sci. Rep. 8, 7083. 10.1038/s41598-018-25008-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25008-4</ArticleId><ArticleId IdType="pmc">PMC5935693</ArticleId><ArticleId IdType="pubmed">29728608</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou, M., Lagier-Tourenne, C., Hutt, K. R., Huelga, S. C., Moran, J., Liang, T. Y., Ling, S.-C., Sun, E., Wancewicz, E., Mazur, C.et al. (2011). Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 14, 459-468. 10.1038/nn.2779</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio, M., Humphrey, J., Pickles, S., Brown, A.-L., Hill, S. E., Kachergus, J. M., Shi, J., Heckman, M. G., Spiegel, M. R., Cook, C.et al. (2020). Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J. Clin. Invest. 130, 6080-6092. 10.1172/JCI139741</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI139741</ArticleId><ArticleId IdType="pmc">PMC7598060</ArticleId><ArticleId IdType="pubmed">32790644</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson, J. T., Thorvaldsd&#xf3;ttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G. and Mesirov, J. P. (2011). Integrative genomics viewer. Nat. Biotechnol. 29, 24-26. 10.1038/nbt.1754</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1754</ArticleId><ArticleId IdType="pmc">PMC3346182</ArticleId><ArticleId IdType="pubmed">21221095</ArticleId></ArticleIdList></Reference><Reference><Citation>Roczniak-Ferguson, A. and Ferguson, S. M. (2019). Pleiotropic requirements for human TDP-43 in the regulation of cell and organelle homeostasis. Life Sci. Alliance 2, e201900358. 10.26508/lsa.201900358</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.201900358</ArticleId><ArticleId IdType="pmc">PMC6749094</ArticleId><ArticleId IdType="pubmed">31527135</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford, N. J., Zhang, Y.-J., Baker, M., Gass, J. M., Finch, N. C. A., Xu, Y.-F., Stewart, H., Kelley, B. J., Kuntz, K., Crook, R. J. P.et al. (2008). Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 4, e1000193. 10.1371/journal.pgen.1000193</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000193</ArticleId><ArticleId IdType="pmc">PMC2527686</ArticleId><ArticleId IdType="pubmed">18802454</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab, C., Arai, T., Hasegawa, M., Yu, S. and Mcgeer, P. L. (2008). Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J. Neuropathol. Exp. Neurol. 67, 1159-1165. 10.1097/NEN.0b013e31818e8951</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31818e8951</ArticleId><ArticleId IdType="pubmed">19018245</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter, E. L., Vance, C., Nishimura, A. L., Lee, Y.-B., Chen, H.-J., Urwin, H., Sardone, V., Mitchell, J. C., Rogelj, B., Rubinsztein, D. C.et al. (2014). Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J. Cell Sci. 127, 1263-1278. 10.1242/jcs.140087</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.140087</ArticleId><ArticleId IdType="pmc">PMC3953816</ArticleId><ArticleId IdType="pubmed">24424030</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton, C. F., Cenik, C., Kucukural, A., Dammer, E. B., Cenik, B., Han, Y. H., Dewey, C. M., Roth, F. P., Herz, J., Peng, J.et al. (2011). Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J. Biol. Chem. 286, 1204-1215. 10.1074/jbc.M110.190884</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.190884</ArticleId><ArticleId IdType="pmc">PMC3020728</ArticleId><ArticleId IdType="pubmed">21051541</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiga, A., Ishihara, T., Miyashita, A., Kuwabara, M., Kato, T., Watanabe, N., Yamahira, A., Kondo, C., Yokoseki, A., Takahashi, M.et al. (2012). Alteration of POLDIP3 splicing associated with loss of function of TDP-43 in tissues affected with ALS. PLoS ONE 7, e43120. 10.1371/journal.pone.0043120</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0043120</ArticleId><ArticleId IdType="pmc">PMC3416794</ArticleId><ArticleId IdType="pubmed">22900096</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, B. N., Ticozzi, N., Fallini, C., Gkazi, A. S., Topp, S., Kenna, K. P., Scotter, E. L., Kost, J., Keagle, P., Miller, J. W.et al. (2014). Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. Neuron 84, 324-331. 10.1016/j.neuron.2014.09.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.09.027</ArticleId><ArticleId IdType="pmc">PMC4521390</ArticleId><ArticleId IdType="pubmed">25374358</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, B. N., Vance, C., Scotter, E. L., Troakes, C., Wong, C. H., Topp, S., Maekawa, S., King, A. and Mitchell, J. C. (2015). Novel mutations support a role for Profilin 1 in the pathogenesis of ALS. Neurobiol. Aging 36, 1602.e17-27. 10.1016/j.neurobiolaging.2014.10.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.10.032</ArticleId><ArticleId IdType="pmc">PMC4357530</ArticleId><ArticleId IdType="pubmed">25499087</ArticleId></ArticleIdList></Reference><Reference><Citation>Soneson, C. and Delorenzi, M. (2013). A comparison of methods for differential expression analysis of RNA-seq data. BMC Bioinformatics 14, 91. 10.1186/1471-2105-14-91</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-91</ArticleId><ArticleId IdType="pmc">PMC3608160</ArticleId><ArticleId IdType="pubmed">23497356</ArticleId></ArticleIdList></Reference><Reference><Citation>Soneson, C., Love, M. I. and Robinson, M. D. (2015). Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res. 4, 1521. 10.12688/f1000research.7563.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.7563.1</ArticleId><ArticleId IdType="pmc">PMC4712774</ArticleId><ArticleId IdType="pubmed">26925227</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E.et al. (2008). TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672. 10.1126/science.1154584</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Stalekar, M., Yin, X., Rebolj, K., Darovic, S., Troakes, C., Mayr, M., Shaw, C. E. and Rogelj, B. (2015). Proteomic analyses reveal that loss of TDP-43 affects RNA processing and intracellular transport. Neuroscience 293, 157-170. 10.1016/j.neuroscience.2015.02.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.02.046</ArticleId><ArticleId IdType="pubmed">25743254</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, S., Law, C. W., Ah-Cann, C., Asselin-Labat, M.-L., Blewitt, M. E. and Ritchie, M. E. (2017). Glimma: interactive graphics for gene expression analysis. Bioinformatics 33, 2050-2052. 10.1093/bioinformatics/btx094</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btx094</ArticleId><ArticleId IdType="pmc">PMC5870845</ArticleId><ArticleId IdType="pubmed">28203714</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki, H., Shibagaki, Y., Hattori, S. and Matsuoka, M. (2015). Nuclear TDP-43 causes neuronal toxicity by escaping from the inhibitory regulation by hnRNPs. Hum. Mol. Genet. 24, 1513-1527. 10.1093/hmg/ddu563</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu563</ArticleId><ArticleId IdType="pubmed">25378556</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey, J. R., Curk, T., Rogelj, B., Briese, M., Cereda, M., Kayikci, M., K&#xf6;nig, J., Hortob&#xe1;gyi, T., Nishimura, A. L., &#x17d;upunski, V.et al. (2011). Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 14, 452-458. 10.1038/nn.2778</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2778</ArticleId><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres, H., Charli, J. L., Gonzalez-Noriega, A., Vargas, M. A. and Joseph-Bravo, P. (1986). Subcellular distribution of the enzymes degrading thyrotropin releasing hormone and metabolites in rat brain. Neurochem. Int. 9, 103-110. 10.1016/0197-0186(86)90038-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-0186(86)90038-0</ArticleId><ArticleId IdType="pubmed">20493107</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziortzouda, P., Van Den Bosch, L. and Hirth, F. (2021). Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation. Nat. Rev. Neurosci. 22, 197-208. 10.1038/s41583-021-00431-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-021-00431-1</ArticleId><ArticleId IdType="pubmed">33654312</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance, C., Rogelj, B., Hortob&#xe1;gyi, T., De Vos, K. J., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P.et al. (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211. 10.1126/science.1165942</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker, A. K., Spiller, K. J., Ge, G., Zheng, A., Xu, Y., Zhou, M., Tripathy, K., Kwong, L. K., Trojanowski, J. Q. and Lee, V. M.-Y. (2015). Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol. 130, 643-660. 10.1007/s00401-015-1460-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1460-x</ArticleId><ArticleId IdType="pmc">PMC5127391</ArticleId><ArticleId IdType="pubmed">26197969</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, S.-H. J., Celic, I., Choi, S.-Y., Riccomagno, M., Wang, Q., Sun, L. O., Mitchell, S. P., Vasioukhin, V., Huganir, R. L. and Kolodkin, A. L. (2014). Dlg5 regulates dendritic spine formation and synaptogenesis by controlling subcellular N-cadherin localization. J. Neurosci. 34, 12745-12761. 10.1523/JNEUROSCI.1280-14.2014</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1280-14.2014</ArticleId><ArticleId IdType="pmc">PMC4166160</ArticleId><ArticleId IdType="pubmed">25232112</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, C., Duan, Y., Duan, G., Wang, Q., Zhang, K., Deng, X., Qian, B., Gu, J., Ma, Z., Zhang, S.et al. (2020). Stress induces dynamic, cytotoxicity-antagonizing TDP-43 nuclear bodies via paraspeckle LncRNA NEAT1-mediated liquid-liquid phase separation. Mol. Cell 79, 443-58.e7. 10.1016/j.molcel.2020.06.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.06.019</ArticleId><ArticleId IdType="pubmed">32649883</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska, I. and Baloh, R. H. (2011). TDP-43-based animal models of neurodegeneration: new insights into ALS pathology and pathophysiology. Neurodegener. Dis. 8, 262-274. 10.1159/000321547</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000321547</ArticleId><ArticleId IdType="pmc">PMC3214943</ArticleId><ArticleId IdType="pubmed">21124004</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M. and Baloh, R. H. (2009). TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA 106, 18809-18814. 10.1073/pnas.0908767106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Wils, H., Kleinberger, G., Janssens, J., Pereson, S., Joris, G., Cuijt, I., Smits, V., Ceuterick-De Groote, C., Van Broeckhoven, C. and Kumar-Singh, S. (2010). TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA 107, 3858-3863. 10.1073/pnas.0912417107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0912417107</ArticleId><ArticleId IdType="pmc">PMC2840518</ArticleId><ArticleId IdType="pubmed">20133711</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton, M. J., Igaz, L. M., Wong, M. M., Kwong, L. K., Trojanowski, J. Q. and Lee, V. M.-Y. (2008). Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 283, 13302-13309. 10.1074/jbc.M800342200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M800342200</ArticleId><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, C.-H., Fallini, C., Ticozzi, N., Keagle, P. J., Sapp, P. C., Piotrowska, K., Lowe, P., Koppers, M., Mckenna-Yasek, D., Baron, D. M.et al. (2012). Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature 488, 499-503. 10.1038/nature11280</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11280</ArticleId><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing, L., Cheng, Q., Zha, G. and Yi, S. (2017). Transcriptional profiling at high temporal resolution reveals robust immune/inflammatory responses during rat sciatic nerve recovery. Mediators Inflamm. 2017, 3827841. 10.1155/2017/3827841</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/3827841</ArticleId><ArticleId IdType="pmc">PMC5405595</ArticleId><ArticleId IdType="pubmed">28490837</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, L., Ke, H., Xu, H., Wang, G.-D., Zhang, H., Zou, L., Xiang, S., Li, M., Peng, L., Zhou, M.et al. (2020). TDP-43 facilitates milk lipid secretion by post-transcriptional regulation of Btn1a1 and Xdh. Nat. Commun.. 11, 341. 10.1038/s41467-019-14183-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-14183-1</ArticleId><ArticleId IdType="pmc">PMC6969145</ArticleId><ArticleId IdType="pubmed">31953403</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziff, O. J., Clarke, B. E., Taha, D. M., Crerar, H., Luscombe, N. M. and Patani, R. (2022). Meta-analysis of human and mouse ALS astrocytes reveals multi-omic signatures of inflammatory reactive states. Genome Res. 32, 71-84. 10.1101/gr.275939.121</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.275939.121</ArticleId><ArticleId IdType="pmc">PMC8744676</ArticleId><ArticleId IdType="pubmed">34963663</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>